Market Overview

UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT on Universal American

Related UAM
Wall Street's M&A Chatter From November 17
15 Biggest Mid-Day Gainers For Thursday

In a report published Monday, the Goldman Sachs Group reiterated its Neutral rating on Universal American Corporation (NYSE: UAM), but slightly lowered its price target from $12.00 to $11.00.

Goldman Sachs noted, “2Q results fell short of our model on operating margins. The company continues to lose leverage from stagnant Medicare Advantage (MA) enrollment and has struggled to significantly cut overhead costs following the divestiture of the Medicare drug business last year. Meanwhile, the key actions for this year have been the company's acquisition of APS Healthcare and the focus on investing in CMS-sponsored Accountable Care Organizations.”

Universal American Corporation closed on Friday at $9.21.

Latest Ratings for UAM

Jan 2017PiperJaffrayInitiates Coverage OnNeutral
Aug 2015BMO CapitalMaintainsMarket Perform
Nov 2014Bank of AmericaMaintainsUnderperform

View More Analyst Ratings for UAM
View the Latest Analyst Ratings

Posted-In: Goldman Sachs GroupAnalyst Color Price Target Analyst Ratings


Related Articles (UAM)

View Comments and Join the Discussion!

Partner Center